- Home
- SHOO vs IRON Comparison
SHOO vs IRON Comparison
Compare SHOO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOO
- IRON
- Stock Information
- Founded
- SHOO 1990
- IRON 2017
- Country
- SHOO United States
- IRON United States
- Employees
- SHOO N/A
- IRON N/A
- Industry
- SHOO Shoe Manufacturing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- SHOO Consumer Discretionary
- IRON Health Care
- Exchange
- SHOO Nasdaq
- IRON Nasdaq
- Market Cap
- SHOO 2.0B
- IRON 2.0B
- IPO Year
- SHOO 1993
- IRON N/A
- Fundamental
- Price
- SHOO $30.32
- IRON $60.76
- Analyst Decision
- SHOO Hold
- IRON Strong Buy
- Analyst Count
- SHOO 7
- IRON 10
- Target Price
- SHOO $27.83
- IRON $97.80
- AVG Volume (30 Days)
- SHOO 1.3M
- IRON 299.1K
- Earning Date
- SHOO 07-30-2025
- IRON 08-07-2025
- Dividend Yield
- SHOO 2.79%
- IRON N/A
- EPS Growth
- SHOO N/A
- IRON N/A
- EPS
- SHOO 1.28
- IRON N/A
- Revenue
- SHOO $2,319,527,000.00
- IRON N/A
- Revenue This Year
- SHOO $11.61
- IRON N/A
- Revenue Next Year
- SHOO $10.13
- IRON N/A
- P/E Ratio
- SHOO $23.61
- IRON N/A
- Revenue Growth
- SHOO 7.97
- IRON N/A
- 52 Week Low
- SHOO $19.05
- IRON $30.82
- 52 Week High
- SHOO $50.01
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- SHOO 67.97
- IRON 56.26
- Support Level
- SHOO $28.91
- IRON $59.74
- Resistance Level
- SHOO $29.77
- IRON $63.51
- Average True Range (ATR)
- SHOO 0.99
- IRON 2.05
- MACD
- SHOO 0.22
- IRON -0.00
- Stochastic Oscillator
- SHOO 88.77
- IRON 44.17
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.